Arca
Skip to content

Endocarditis

Drug research and approvals for endocarditis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 17, 2026, 37 studies of endocarditis are recruiting on ClinicalTrials.gov, Health Canada has authorized 1 drug trials for it since 2013, and FDA has 0 approved and 1 open orphan designations naming it.

  • Recruiting worldwide: 37
  • Trials authorized in Canada: 1
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 37 recruiting on ClinicalTrials.gov ↗

Drug Pipeline

6 approved, 3 in phase 3, 3 in phase 2; from ChEMBL's drug indications, furthest stage reached for this condition

Approved: Vancomycin, Daptomycin, Cilastatin, Cefazolin, Ampicillin, Imipenem anhydrous

Rifampin
Phase 3 Bacterial DNA-directed RNA polymerase inhibitor
Amoxicillin
Phase 3 Bacterial penicillin-binding protein inhibitor
Levofloxacin anhydrous
Phase 3 DNA gyrase inhibitor
Ceftriaxone
Phase 2 Bacterial penicillin-binding protein inhibitor
Oxygen
Phase 2 Essential for cellular homeostasis

How Its Trials Ended

162 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 27 whose ending is known, 19% met their primary endpoint, 15% missed it and 67% stopped early.

  • Ongoing5534%
  • Completed, result not reported4528%
  • Status unknown3522%
  • Stopped: other or unclear74%
  • Stopped: enrollment or feasibility64%
  • Met its primary endpoint53%
  • Missed its primary endpoint42%
  • Stopped: lack of efficacy32%
  • Stopped: sponsor or business decision11%
  • Stopped: funding11%

Trials Authorized in Canada

Newest first; search them all in Canada trials
AuthorizedTrialSponsorStatus
Aug 2, 2024Adjunctive rifampin for the treatment of prosthetic valve endocarditis due to s. aureus (rifa-snap)RifampinResearch Institute Of The Mcgill University Health CentreClosed

FDA Orphan Designations

Approved first, then open designations, newest first
DateDrugSponsorStatus
Jun 10, 2024CalpurbatugTreatment of infective endocarditisTrellis Bioscience Inc.Designated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.